MLL
TMO icon

Moody Lynn & Lieberson’s Thermo Fisher Scientific TMO Stock Holding History

Moody Lynn & Lieberson’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Sell
40,920
-1,554
-4% -$746K 1.08% 24
2026
Q1 		$20.9M Buy
42,474
+1,543
+4% +$837K 1.17% 26
2025
Q4 		$23.7M Buy
40,931
+979
+2% +$554K 1.26% 24
2025
Q3 		$19.4M Buy
39,952
+112
+0.3% +$52.1K 1.04% 26
2025
Q2 		$16.2M Sell
39,840
-6,336
-14% -$2.65M 0.93% 25
2025
Q1 		$23M Sell
46,176
-3,674
-7% -$1.99M 1.47% 23
2024
Q4 		$25.9M Sell
49,850
-5,127
-9% -$2.82M 1.59% 22
2024
Q3 		$34M Buy
54,977
+5,414
+11% +$3.2M 2.1% 15
2024
Q2 		$27.4M Buy
49,563
+325
+0.7% +$186K 1.79% 15
2024
Q1 		$28.6M Buy
49,238
+232
+0.5% +$130K 1.92% 16
2023
Q4 		$26M Sell
49,006
-132
-0.3% -$63.9K 1.98% 15
2023
Q3 		$24.9M Buy
49,138
+43
+0.1% +$22.9K 2.13% 13
2023
Q2 		$25.6M Buy
49,095
+852
+2% +$460K 2.07% 11
2023
Q1 		$27.8M Buy
48,243
+43
+0.1% +$24.2K 2.5% 9
2022
Q4 		$26.5M Sell
48,200
-11,507
-19% -$6.1M 2.43% 9
2022
Q3 		$30.3M Sell
59,707
-966
-2% -$541K 2.92% 5
2022
Q2 		$33M Sell
60,673
-6,042
-9% -$3.33M 2.97% 6
2022
Q1 		$39.4M Sell
66,715
-3,097
-4% -$1.78M 2.88% 6
2021
Q4 		$46.6M Sell
69,812
-28
-0% -$17.5K 3.13% 5
2021
Q3 		$39.9M Sell
69,840
-1,266
-2% -$695K 2.99% 6
2021
Q2 		$35.9M Sell
71,106
-1,364
-2% -$644K 2.7% 7
2021
Q1 		$33.1M Sell
72,470
-7,170
-9% -$3.42M 2.75% 6
2020
Q4 		$37.1M Sell
79,640
-1,656
-2% -$776K 3.18% 4
2020
Q3 		$35.9M Buy
81,296
+213
+0.3% +$88K 3.56% 4
2020
Q2 		$29.4M Sell
81,083
-6,299
-7% -$2.11M 3.19% 6
2020
Q1 		$24.8K Buy
87,382
+10,070
+13% +$3.18M 3.41% 5
2019
Q4 		$25.1M Buy
77,312
+1,900
+3% +$576K 2.42% 8
2019
Q3 		$22M Sell
75,412
-15,682
-17% -$4.49M 2.45% 8
2019
Q2 		$26.8M Sell
91,094
-296
-0.3% -$81.5K 2.94% 4
2019
Q1 		$25M Buy
91,390
+806
+0.9% +$201K 2.87% 5
2018
Q4 		$20.3M Buy
90,584
+9,650
+12% +$2.26M 2.72% 7
2018
Q3 		$19.8M Buy
80,934
+10,850
+15% +$2.5M 2.1% 11
2018
Q2 		$14.5M Sell
70,084
-27
-0% -$5.73K 1.71% 17
2018
Q1 		$14.5M Sell
70,111
-966
-1% -$203K 1.75% 18
2017
Q4 		$15.3M Sell
71,077
-6,516
-8% -$1.25M 1.63% 18
2017
Q3 		$14.7M Buy
77,593
+15,018
+24% +$2.72M 1.79% 20
2017
Q2 		$10.9M Buy
62,575
+1,480
+2% +$249K 1.43% 26
2017
Q1 		$9.38M Sell
61,095
-27,830
-31% -$4.25M 1.32% 31
2016
Q4 		$12.5M Buy
88,925
+26,950
+43% +$3.97M 1.8% 15
2016
Q3 		$9.86M Sell
61,975
-2,007
-3% -$309K 1.64% 18
2016
Q2 		$9.45M Sell
63,982
-2,107
-3% -$311K 1.69% 18
2016
Q1 		$9.36M Buy
66,089
+21,130
+47% +$2.83M 1.47% 21
2015
Q4 		$6.38M Buy
44,959
+3,580
+9% +$477K 1% 36
2015
Q3 		$5.06M Sell
41,379
-70,448
-63% -$9.18M 0.97% 41
2015
Q2 		$14.5M Buy
+111,827
New +$14.6M 2.31% 10

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Moody Lynn & Lieberson's TMO Position: Q2 2026 in Review

Moody Lynn & Lieberson reduced its Thermo Fisher Scientific (TMO) stake by 3.7% in Q2 2026, selling an estimated $746K and leaving 40,920 shares worth $20.5M. The position accounts for 1.08% of the portfolio, ranked #24.

Moody Lynn & Lieberson first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $46.6M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Moody Lynn & Lieberson held 40,920 shares of Thermo Fisher Scientific worth $20.5M as of Q2 2026.
  • Moody Lynn & Lieberson sold 1,554 Thermo Fisher Scientific shares in Q2 2026, an estimated $746K.
  • Thermo Fisher Scientific made up 1.08% of Moody Lynn & Lieberson's portfolio in Q2 2026, its #24 holding.
  • Moody Lynn & Lieberson first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
  • Moody Lynn & Lieberson's Thermo Fisher Scientific position peaked at $46.6M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.